Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YAZ in women with moderate acne
NCT00818519Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in acne vulgaris, sponsored by Bayer. Started Dec 2008; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00818519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818519.